Mounjaro (tirzepatide): summary of product characteristics 2023
Harnessing incretin hormones beyond GLP-1: novel incretin combinations There is increasing interest in other incretin hormones that may act on the kidney
have divulged glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 1 diabetes, atherosclerosis, type 2 diabetes, obesity, nonalcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH), hypertension, diabetic complications and coronary heart disease among others
Novo Nordisk isnt happy that Hims & Hers is exploiting a loophole
BPC-157 : performance, recovery + immune support Description Peptide known for its potential to support healing, tissue repair, and gut health by promoting cellular regeneration and reducing inflammation
[PubMed: 13975314] 502